906 followers
New article: Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review https://t.co/W6sabS9F5m #colorectalcancer #oncology https://t.co/aLqZRtXkMH
New article: Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review https://t.co/W6sabS9F5m #colorectalcancer #oncology https://t.co/aLqZRtXkMH
New Research: Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review https://t.co/bE6I2UsTu2 #pharmacology
Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of BRAFV600E-Mutant CRC: A Case Report and Review https://t.co/9rP4Vb3hZE